HOME >> MEDICINE >> NEWS
Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction

Researchers at the University of Washington School of Medicine have performed the first randomized controlled clinical trial showing that a painful and even life-threatening bowel condition called acute colonic pseudo-obstruction can be effectively treated with intravenous neostigmine.

Results of the study will be published in the July 15 issue of the New England Journal of Medicine. However, the journal is releasing the study seven weeks early on its Web site, http://www.nejm.org, to ensure that doctors who treat the condition are notified as quickly as possible. The article is entitled "Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction."

Acute colonic pseudo-obstruction occurs in some hospitalized patients following surgery or severe medical illness. The condition is caused by a loss of normal motility or spontaneous bowel action. Also called Ogilvie's syndrome, it causes a severely distended colon (large intestine).

If conservative treatments to restore normal bowel function are not successful, some patients require colonic decompression by emergency colonoscopy or surgery, to prevent ischemia (cutoff of blood supply to the bowel) or perforation of the bowel. Some 3 percent of patients with the condition suffer a perforated bowel and half of those patients die.

In this prospective, double-blind, placebo-controlled trial, Drs. Robert J. Ponec, Michael D. Sanders and Michael B. Kimmey of the Division of Gastroenterology at University of Washington Medical Center confirm earlier uncontrolled studies showing that treatment with intravenous neostigmine is effective in relieving the condition.

The UW study involved 21 patients with a wide range of medical and surgical diagnoses, who had marked abdominal distention and dilated colon and who had failed to improve after 24 hours of conservative treatment. (Conservative treatment included nothing by m
'"/>

Contact: Laurie McHale
lmchale@u.washington.edu
206-543-3620
University of Washington
25-May-1999


Page: 1 2

Related medicine news :

1. Retrospective Statistical Analysis Corroborates Early Results Of Randomized Breast Cancer Trials
2. Treatment Of Distal Ureteral Stones: ESWL Versus URS: A Prospective Randomized Study
3. Randomized Placebo-Controlled Study On The Effects Of Oral Treatment With GinkgoBiloba Extract In Patients With Erectile Dysfunction
4. Study of energy and health in Africa focuses spotlight on charcoal and forest management
5. Study shows promise in identifying kidney failure
6. Study shows patch therapy may be as effective as oral medications
7. Study shows soy is well accepted in school lunches
8. Study finds that coordinating care of chronically ill patients does not increase liability
9. Study provides new estimates of the causes of child mortality worldwide
10. Study finds factors linked to substance use disorder relapse among health care professionals
11. Study finds majority of women willing to accept cervical cancer vaccine for self and children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... ... September 17, 2019 , ... Since the registration ... Century Cures Act in the US, Nocimed has been marketing its unique technology ... images from existing MRI equipment to perform MR spectroscopy, NociScan detects the presence ...
(Date:9/17/2019)... Village, CA (PRWEB) , ... September 17, 2019 ... ... in Westlake Village, CA, incision-free treatment with laser dentistry . A minimally ... to perform than traditional osseous surgery. , Laser dentistry is gentle and ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... largest accountable care organization (ACO) in the country, the company announced today. High-performing ... to improve care quality and increase cost efficiency. This opportunity is open to ...
(Date:9/17/2019)... ... , ... Lubin Austermuehle, P.C. will be one of the sponsors ... held at Found Kitchen and Social House in Evanston on Monday, October 7 from ... Disorder, a rare condition that results from changes to the GRIN2B gene. The GRIN2B ...
(Date:9/17/2019)... ... September 17, 2019 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for Japan . Leading companies ... their EHS regulatory obligations and rapidly collect, share, archive, and export audit findings ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Today, in partnership with ... contraception and consent with student and faculty from The City University of New ... Francisco Ramirez, MPH; Elise Schuster, MPH; Raffaele M. Bernardo, DO, FACP, AAHIVS and ...
(Date:9/17/2019)... ... September 17, 2019 , ... Embr Labs , the ... Series B funding led by DigiTx Partners, with participation from Safar Partners, ... use the investment to grow the company’s footprint in wellness and digital therapeutics, accelerate ...
(Date:9/17/2019)... ... September 17, 2019 , ... Gustavo Grodnitzky, PhD will join the ... Yoga Science as holistic mind/body medicine for physicians and other health care professionals. Entitled ... 22-26, 2019 at the Cranwell Resort and Spa in Lenox, Massachusetts, is accredited by ...
Breaking Medicine Technology:
Cached News: